TRxADE HEALTH, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 8.27 million compared to USD 10.25 million a year ago. Net loss was USD 17.84 million compared to USD 3.47 million a year ago.

Basic loss per share from continuing operations was USD 17.96 compared to USD 3.48 a year ago. Basic loss per share was USD 23.35 compared to USD 6.15 a year ago.